Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Curious about which cash back credit cards don't charge an annual fee? Discover options that allow you to earn rewards without extra costs.
26,317 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
JPMorgan and Mastercard joined Ripple and Ondo Finance to settle a tokenized US Treasury redemption on the XRP Ledger...
Solana just posted a landmark quarter with over $1 trillion in on-chain activity. This article unpacks what that mile...
A private Greek ceremony highlights privacy, luxury, and budgeting. This guide breaks down costs, planning steps, and...
Three Dow components power the year’s rally with double-digit gains. Honeywell’s split plan and Chevron’s rising prod...
U.S. equities climbed on Friday as top performing stocks led a broad rally, with technology and energy names pushing ...
Mega IPOs spark big bets and bigger headlines. This guide unpacks whether elon musk selling 'hopium' is fueling Space...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
Retirees cling to a low-cost dividend ETF that advisors often push, yet most seniors can’t recall the ticker. This re...
SpaceX is gearing up for a historic IPO. This article breaks down the crucial detail SpaceX announced important detai...
A growing alliance between Alphabet and Anthropic could redefine how AI is trained and deployed. This piece breaks do...
A higher 2027 COLA could meaningfully increase your Social Security benefits, but the impact varies by state and pers...